Literature DB >> 2890020

Hypersensitivity to G2 chromatid radiation damage in familial dysplastic naevus syndrome.

K K Sanford1, R E Tarone, R Parshad, M A Tucker, M H Greene, G M Jones.   

Abstract

Skin fibroblasts from 25 members of nine kindreds with familial dysplastic naevus syndrome (DNS), 12 apparently normal spouses, and 11 additional unrelated normal individuals were tested for G2 cell-cycle phase sensitivity to ionising radiation. The cells from individuals with DNS or hereditary cutaneous malignant melanoma with DNS (HCMM/DNS) had significantly more chromatid breaks and gaps when entering metaphase 0.5-1.5 h after G2 phase X-irradiation (1 Gy) than those from unaffected controls. In two cases, the test results positively identified individuals before the clinical diagnosis of DNS. A clinically normal obligate carrier of the HCMM/DNS gene showed the enhanced G2 radiosensitivity. Moreover, in a test on 1 proband, the sensitivity was apparent in peripheral blood lymphoblasts. Enhanced G2 chromatid radiosensitivity may be a marker of genetic susceptibility to HCMM/DNS.

Entities:  

Mesh:

Year:  1987        PMID: 2890020     DOI: 10.1016/s0140-6736(87)91546-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls.

Authors:  J K Wiencke; D W Wara; J B Little; K T Kelsey
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

2.  DNA repair synthesis following irradiation with 254-nm and 312-nm ultraviolet light is not diminished in fibroblasts from patients with dysplastic nevus syndrome.

Authors:  H W Thielmann; O Popanda; L Edler; A Böing; E G Jung
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  G2 chromosomal radiosensitivity in families with ataxia-telangiectasia.

Authors:  Y Shiloh; R Parshad; M Frydman; K K Sanford; S Portnoi; Y Ziv; G M Jones
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

Review 4.  Cytogenetics of human malignant melanoma.

Authors:  J M Trent
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

5.  Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.

Authors:  P Rudolph; T Lappe; C Schubert; D Schmidt; R M Parwaresch; E Christophers
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

6.  Increased breakage of chromosome 1 in lymphocytes of patients with testicular cancer after bleomycin treatment in vitro.

Authors:  I Vorechovsky; J Zaloudik
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

7.  Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition?

Authors:  D Scott; J B Barber; E L Levine; W Burrill; S A Roberts
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

8.  Deficient DNA repair capacity, a predisposing factor in breast cancer.

Authors:  R Parshad; F M Price; V A Bohr; K H Cowans; J A Zujewski; K K Sanford
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.